XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.1
COMMITMENTS AND CONTINGENCIES (Details Narrative)
$ / shares in Units, ₪ in Thousands, $ in Thousands
1 Months Ended 3 Months Ended
Mar. 30, 2021
USD ($)
Dec. 18, 2020
USD ($)
Apr. 28, 2019
USD ($)
May 25, 2018
USD ($)
shares
Jan. 04, 2018
USD ($)
$ / shares
Jan. 04, 2018
ILS (₪)
Jan. 04, 2018
USD ($)
$ / shares
Jun. 30, 2012
Mar. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
$ / shares
Jun. 10, 2021
USD ($)
$ / shares
Loss Contingencies [Line Items]                      
Common stock par value | $ / shares                 $ 0.01 $ 0.01  
Joseph Mona [Member]                      
Loss Contingencies [Line Items]                      
Purchase price of plaintiffs $ 484                    
Securities Purchase Agreement [Member]                      
Loss Contingencies [Line Items]                      
Settlement amount                 $ 3,700    
Number of post-stock split shares returned | shares                 83,333    
Purchase price of plaintiffs                 $ 6,750    
Israeli Innovation Authority [Member] | CardioSert Ltd [Member]                      
Loss Contingencies [Line Items]                      
Repayment of government grants             $ 530        
Technion Research and Development Foundation Limited [Member] | Minimum [Member]                      
Loss Contingencies [Line Items]                      
Royalties payable as percentage of future sales               1.50%      
Technion Research and Development Foundation Limited [Member] | Maximum [Member]                      
Loss Contingencies [Line Items]                      
Royalties payable as percentage of future sales               3.00%      
CardioSert Ltd [Member] | Technology [Member]                      
Loss Contingencies [Line Items]                      
Initial payment       $ 250 $ 50            
Number of common shares issued for acquisition | shares       6,738              
Number of common shares issued for acquisition, value       $ 74              
Buy back amount per patent | $ / shares         $ 1.00   $ 1.00        
Monthly consultation fee | ₪           ₪ 40,000          
Currency exchange rate, description         exchange rate of NIS 3.176 to the dollar exchange rate of NIS 3.176 to the dollar          
CardioSert Ltd [Member] | Minimum [Member] | Technology [Member]                      
Loss Contingencies [Line Items]                      
Investments         $ 2,000   $ 2,000        
H.C. Wainwright & Co. LLC [Member] | At-the-Market Offering Agreement [Member]                      
Loss Contingencies [Line Items]                      
Common stock par value | $ / shares                     $ 0.01
Offering costs                     $ 10,000
Alliance Investment Management, Ltd. [Member]                      
Loss Contingencies [Line Items]                      
Litigation settlement   $ 485 $ 468                
Loss on settlement     $ 151                
2013 Through March 31, 2022 [Member] | Israeli Innovation Authority [Member]                      
Loss Contingencies [Line Items]                      
Revenue from Contract with Customer, Including Assessed Tax                 $ 1,500    
2013 Through March 31, 2022 [Member] | Israeli Innovation Authority [Member] | Minimum [Member]                      
Loss Contingencies [Line Items]                      
Royalties payable as percentage of future sales                 3.00%    
2013 Through March 31, 2022 [Member] | Israeli Innovation Authority [Member] | Maximum [Member]                      
Loss Contingencies [Line Items]                      
Royalties payable as percentage of future sales                 3.50%